Self-Amplifying RNA Vaccines With Composite Lipid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for enhanced efficiency in the production of vaccines and the development of vaccines that are less susceptible to being evaded by infectious disease agents, particularly for viral, bacterial, and parasitic diseases, with influenza being a significant concern due to its high mortality rates and rapid mutation capabilities.
Innovation Solution
Compositions comprising a lipid carrier with specific surfactants and nucleic acids encoding antigen sequences, including a nanoemulsion formulation with DOTAP chloride, squalene, sorbitan monostearate, polysorbate 80, and oleic acid-coated iron oxide nanoparticles, are developed to deliver antigens effectively, inducing an immune response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional vaccine production methods are used, then production processes are well-established, but production efficiency is insufficient and vaccines can be easily evaded by infectious disease agents
Solution Approach 1:
The patent employs RNA technology with self-amplifying replicons that change the fundamental parameter of antigen production from static (traditional vaccines) to dynamic self-replicating systems, enabling rapid production scaling and enhanced immunogenicity to counter evolving pathogens
Solution Approach 2:
The vaccine composition uses composite lipid nanoparticle formulations combining multiple lipids and surfactants to deliver RNA antigens, creating a multifunctional delivery system that enhances both production efficiency and effectiveness against varying pathogens
2Productivity
If RNA vaccines with self-amplifying replicons are used, then immune response is enhanced and production efficiency improves, but formulation complexity increases
Solution Approach 1:
Lipid nanoparticles serve as intermediary carriers that simplify the delivery of complex self-amplifying RNA replicons, protecting the RNA and facilitating cellular uptake while maintaining manageable formulation processes
Solution Approach 2:
The lipid nanoparticle formulation serves multiple functions simultaneously: protecting RNA from degradation, facilitating cellular entry, enabling self-amplification, and enhancing immune response, thereby managing complexity through multi-functional design
3Adaptability or versatility
If conventional vaccine platforms are used, then manufacturing processes are simpler, but adaptability to new infectious diseases is limited
Solution Approach 1:
The vaccine system uses dynamic self-amplifying RNA replicons that can be rapidly reconfigured to target new pathogens, allowing the manufacturing process to adapt quickly to emerging diseases while maintaining efficient production through standardized lipid nanoparticle delivery platforms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described compositions induce a robust immune response, reducing the severity of infections by delivering antigens efficiently and enhancing immunoprotection against infectious diseases.
Implementation Method 1
Compositions comprising a lipid carrier with specific surfactants and nucleic acids encoding antigen sequences, including a nanoemulsion formulation with DOTAP chloride, squalene, sorbitan monostearate, polysorbate 80, and oleic acid-coated iron oxide nanoparticles, are developed to deliver antigens effectively
Implementation Method 2
oleic acid-coated iron oxide nanoparticles, wherein the oleic acid-coated iron oxide nanoparticle range in size from about 5 nanometers up to 25 nm
Data Source
AI summary
The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Methods of using these compositions as a vaccine for treatment of an infectious disease are also provided.